Union Cabinet NOD to Silvassa Medical College, 150 MBBS seats to be added

Published On 2018-11-22 09:18 GMT   |   Update On 2018-11-22 09:18 GMT

New Delhi: The Union Cabinet chaired by Prime Minister Shri Narendra Modi has approved the setting up of Medical College at Silvassa in the Union Territory (UT) of Dadra and Nagar Haveli.


The approval will increase the availability of doctors and address the issue of shortage of doctors.. It will enhance medical education opportunities to students of the two UTs. It will also result in the optimal utilization of the existing infrastructure of district hospitals and improve tertiary care facilities for the people of the two UTs and adjoining areas.

The Medical College will benefit the students, especially those of tribal and rural areas of the two UTs, which will promote social equity. Health equity will be promoted by the provision of better services through improvement in the strength of doctors in the UTs.

Salient Features:




  1. Setting up of the medical college at Silvassa, UT Administration of Dadra and Nagar Haveli at a capital cost of Rs. 189 crore to be incurred in two years, 2018-19 – Rs. 114 crore and 2019-20 – Rs. 75 crore with yearly intake of 150 students.

  2. The project will be completed by 2019-20 and the construction and capital expenditure will be incurred as per the norms of Medical Council of India (MCI) norms and extant guidelines of the Ministry of Health & Family Welfare.

  3. The annual recurring expenditure for the Medical College shall be managed within the budget provision for the UT.

  4. Creation of 21 regular posts of 14 (JS) level and above (including teaching and non-teaching) out of 357 regular posts which were recommended by the Committee on Establishment Expenditure (CEE).



Article Source : Government Press Release

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News